The South African Tuberculosis Vaccine Initiative invites applications for a Postdoctoral Fellowship to conduct research on the Immunology of TB vaccines. NOW CLOSED.
SATVI researchers have published an article titled: "Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial" appearing in the latest Lancet Respiratory Medicine.
On the eve of World TB Day we launched the "TB under the Spotlight Science Engagement" initiative in Worcester in partnership with the Division of Molecular Biology and Human Genetics at the University Stellenbosch and the Department of Education on Tuesday 20 March 2018.
Read the latest news about the fight against TB in the Cape Winelands.